Rigel Pharmaceuticals Inc (RIGL)
1.05
-0.06
(-5.41%)
USD |
NASDAQ |
Apr 18, 16:00
1.06
+0.01
(+0.95%)
After-Hours: 20:00
Rigel Pharmaceuticals Total Assets (Quarterly): 117.22M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 117.22M |
| September 30, 2023 | 115.32M |
| June 30, 2023 | 117.09M |
| March 31, 2023 | 123.61M |
| December 31, 2022 | 134.28M |
| September 30, 2022 | 115.61M |
| June 30, 2022 | 128.00M |
| March 31, 2022 | 149.07M |
| December 31, 2021 | 167.33M |
| September 30, 2021 | 186.52M |
| June 30, 2021 | 201.60M |
| March 31, 2021 | 215.99M |
| December 31, 2020 | 110.38M |
| September 30, 2020 | 123.06M |
| June 30, 2020 | 138.04M |
| March 31, 2020 | 143.36M |
| December 31, 2019 | 147.57M |
| September 30, 2019 | 156.06M |
| June 30, 2019 | 156.16M |
| March 31, 2019 | 172.78M |
| December 31, 2018 | 139.11M |
| September 30, 2018 | 123.17M |
| June 30, 2018 | 141.22M |
| March 31, 2018 | 98.81M |
| December 31, 2017 | 119.11M |
| Date | Value |
|---|---|
| September 30, 2017 | 71.25M |
| June 30, 2017 | 85.48M |
| March 31, 2017 | 101.33M |
| December 31, 2016 | 78.13M |
| September 30, 2016 | 88.64M |
| June 30, 2016 | 99.32M |
| March 31, 2016 | 108.28M |
| December 31, 2015 | 131.75M |
| September 30, 2015 | 139.17M |
| June 30, 2015 | 148.35M |
| March 31, 2015 | 165.69M |
| December 31, 2014 | 154.14M |
| September 30, 2014 | 163.22M |
| June 30, 2014 | 182.43M |
| March 31, 2014 | 203.29M |
| December 31, 2013 | 226.06M |
| September 30, 2013 | 239.54M |
| June 30, 2013 | 261.67M |
| March 31, 2013 | 282.94M |
| December 31, 2012 | 310.04M |
| September 30, 2012 | 194.32M |
| June 30, 2012 | 214.36M |
| March 31, 2012 | 233.91M |
| December 31, 2011 | 257.11M |
| September 30, 2011 | 275.86M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
110.38M
Minimum
Dec 2020
215.99M
Maximum
Mar 2021
144.54M
Average
138.04M
Median
Jun 2020
Total Assets (Quarterly) Benchmarks
| Nektar Therapeutics | 398.03M |
| Avid Bioservices Inc | 454.64M |
| Stereotaxis Inc | 41.91M |
| Cara Therapeutics Inc | 125.84M |
| Blueprint Medicines Corp | 1.049B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 145.87M |
| Shareholders Equity (Quarterly) | -28.64M |
| Debt to Equity Ratio | -2.081 |
| Current Ratio | 1.864 |
| Net Debt Paydown Yield | -1.59% |